Group One Trading’s Organogenesis Holdings ORGO Stock Holding History

Group One Trading’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,800	Closed	-$18.4K	–	8876
2025 Q3	$16K	Buy	+3,800	New	+$17.7K	﹤0.01%	6864
2024 Q4	–	Sell	-2,800	Closed	-$9.39K	–	7770
2024 Q3	$8.01K	Sell	2,800 -700	-20%	-$1.96K	﹤0.01%	5702
2024 Q2	$9.8K	Buy	3,500 +2,212	+172%	+$5.94K	﹤0.01%	5658
2024 Q1	$3.66K	Sell	1,288 -4,667	-78%	-$15.9K	﹤0.01%	6308
2023 Q4	$24.4K	Sell	5,955 -4,811	-45%	-$13.5K	﹤0.01%	5596
2023 Q3	$34.2K	Buy	+10,766	New	+$34.2K	﹤0.01%	5436
2023 Q2	–	Sell	-4,000	Closed	-$11.8K	–	8058
2023 Q1	$8.52K	Buy	+4,000	New	+$9.88K	﹤0.01%	6026
2022 Q4	–	Sell	-1,619	Closed	-$5K	–	7864
2022 Q3	$5K	Sell	1,619 -100	-6%	-$452	﹤0.01%	6839
2022 Q2	$8K	Sell	1,719 -24,998	-94%	-$154K	﹤0.01%	6878
2022 Q1	$204K	Sell	26,717 -10,475	-28%	-$81.1K	﹤0.01%	4777
2021 Q4	$344K	Buy	+37,192	New	+$395K	﹤0.01%	4530

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Group One Trading's ORGO Position: Q4 2025 in Review

Group One Trading sold out of Organogenesis Holdings (ORGO) in Q4 2025, closing a stake of 3,800 shares — an estimated $18.4K sold.

Group One Trading first reported a position in ORGO in Q4 2021 and held it in 11 quarters. The position peaked at $344K in Q4 2021. 147 funds tracked by Wall St. Rank hold ORGO as of Q4 2025.

Group One Trading reported no remaining Organogenesis Holdings position as of Q4 2025 after selling out during the quarter.
Group One Trading sold 3,800 Organogenesis Holdings shares in Q4 2025, an estimated $18.4K.
Group One Trading first reported a position in Organogenesis Holdings in Q4 2021 and held it in 11 quarters.
Group One Trading's Organogenesis Holdings position peaked at $344K in Q4 2021.
147 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.